- TRADE NAMES: Navane (Pfizer); Orbinamon
  - INDICATIONS: Psychotic disorders
 - CLASS: Antipsychotic
 - HALF-LIFE: >24 hours
 
  
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
None known 
  
Please login to view the rest of this drug profile.
 
Page last updated 08/20/2025